Is VPRO or XYLD a better dividend investment in 2026?

VPRO currently yields 10000000.00% with a 5% 5-year dividend growth rate. XYLD yields 11.20% with 0.5% growth. The better choice depends on your goal: VPRO offers higher current income.

What is the dividend yield difference between VPRO and XYLD?

VPRO has a forward dividend yield of 10000000.00% ($2.00/share annually). XYLD yields 11.20% ($4.30/share annually). The yield gap is 9999988.80 percentage points.

Home › Compare › VPRO vs XYLD

VPRO vs XYLD: Dividend Comparison 2026

VPRO yields 10000000.00% · XYLD yields 11.20%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VPRO wins by $4.762052817831319e+46M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VPRO

● Live price

10000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.762052817831319e+46M

Annual income

$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00

Full VPRO calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

11.20%

Share price

$38.36

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$3,351.03

Full XYLD calculator →

Portfolio growth — VPRO vs XYLD

📍 VPRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VPRO	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VPRO + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VPRO pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPRO

Annual income on $10K today (after 15% tax)

$850,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$40,476,652,714,542,950,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

XYLD

Annual income on $10K today (after 15% tax)

$952.37/yr

After 10yr DRIP, annual income (after tax)

$2,848.38/yr

At 15% tax rate, VPRO beats the other by $40,476,652,714,542,950,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPRO + XYLD for your $10,000?

VPRO: 50%XYLD: 50%

100% XYLD50/50100% VPRO

Portfolio after 10yr

$2.3810264089156593e+46M

Annual income

$23,809,795,714,437,028,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPRO buys

XYLD buys

No recent congressional trades found for VPRO or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVPROXYLD

Forward yield	10000000.00% ✓	11.20%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.762052817831319e+46M	$25.9K ✓
Annual income after 10y	$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$3,351.03
Total dividends collected	$4.762046689458665e+46M	$20.2K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: VPRO vs XYLD ($10,000, DRIP)

Year	VPRO Portfolio	VPRO Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$1,000,010,700	$1,000,000,000.00	$10,840	$1,120.44	+$1000.00M → VPRO
2	$93,460,013,936,683	$93,458,943,925,233.62	$11,786	$1,249.59	+$93460013.92M → VPRO
3	$8,163,259,573,940,183,000	$8,163,159,571,725,270,000.00	$12,854	$1,397.78	+$8163259573940.17M → VPRO
4	$666,373,880,559,373,300,000,000	$666,365,145,871,629,100,000,000.00	$14,063	$1,568.33	+$666373880559373312.00M → VPRO
5	$50,838,057,311,279,720,000,000,000,000	$50,837,344,291,227,520,000,000,000,000.00	$15,434	$1,765.19	+$5.083805731127972e+22M → VPRO
6	$3,624,737,622,195,432,400,000,000,000,000,000	$3,624,683,225,474,109,500,000,000,000,000,000.00	$16,995	$1,993.14	+$3.6247376221954326e+27M → VPRO
7	$241,535,451,261,763,920,000,000,000,000,000,000,000	$241,531,572,792,508,160,000,000,000,000,000,000,000.00	$18,777	$2,257.95	+$2.4153545126176394e+32M → VPRO
8	$15,041,872,435,857,020,000,000,000,000,000,000,000,000,000	$15,041,613,992,924,168,000,000,000,000,000,000,000,000,000.00	$20,818	$2,566.58	+$1.504187243585702e+37M → VPRO
9	$875,466,765,540,973,800,000,000,000,000,000,000,000,000,000,000	$875,450,670,737,467,500,000,000,000,000,000,000,000,000,000,000.00	$23,163	$2,927.50	+$8.754667655409739e+41M → VPRO
10	$47,620,528,178,313,184,000,000,000,000,000,000,000,000,000,000,000,000	$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00	$25,865	$3,351.03	+$4.762052817831319e+46M → VPRO

VPRO vs XYLD: Complete Analysis 2026

VPRO — Stock

Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases, such as cancer, diabetes, hepatitis, or multiple sclerosis. It manufactures biologics drugs, including bio-similars for pre-clinical, and Phase I, II, and III clinical trials; offers its clients with supply of mammalian cell proteins, such as monoclonal antibodies or recombinant proteins, or other cell-derived products; owns three clones that include two in insulin therapy and one for cancer therapy; and provides contractual research and manufacturing services to biotech and biopharmaceutical companies. The company's contractual work activities include cloning, sequencing, purifying, developing, validating, and producing biopharmaceutical products and sub-products. It has operations in Canada, the United Kingdom, and Malaysia. Viropro Inc. has collaboration agreement with Oncobiologics, Inc. to manufacture and commercialize monoclonal antibody products. The company is based in San Jose, California. Viropro Inc. is a subsidiary of Alpha Biologics Limited.

Full VPRO Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this VPRO vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPRO vs SCHD VPRO vs JEPI VPRO vs O VPRO vs KO VPRO vs MAIN VPRO vs QYLD VPRO vs JEPQ VPRO vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.